Skip to main content

Table 1 Schedule of enrolment, interventions and assessments adapted from the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure

From: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

 

Screening

Week 1

Week 2

Week 4

Week 6

Week 8

Week 10

Week 16

Study day

≤D0

D1

D2

D3

D4

D5

D6

D7

D8

D9

D10

D11

D12

D13

D14

Consent and randomisation

 Eligibility criteria

X

X

                  

 PIS and signed consent

X

X

                  

 Randomisation

X

X

                  

Treatment

 Intervention: Ambisome 10 mg/kg

 

X

                  

 Intervention: Fluconazole 1200 mg/day

 

X

X

X

X

X

X

X

X

X

X

X

X

X

X

     

 Intervention: Flucytosine 100 mg/kg/day

 

X

X

X

X

X

X

X

X

X

X

X

X

X

X

     

 Control: Amphotericin B deoxycholate 1 mg/kg

 

X

X

X

X

X

X

X

            

 Control: Flucytosine 100 mg/kg/day

 

X

X

X

X

X

X

X

            

 Control: Fluconazole 1200 mg/day

        

X

X

X

X

X

X

X

     

 All participants: Fluconazole 800 mg/day

              

X

X

X

X

X

 

 All participants: 200 mg/day

                  

X

X

Clinical, safety and compliance assessment

 Inpatient clinical review

 

X

X

X

X

X

X

X

X

X

X

X

X

X

X

     

 Outpatient follow-up

               

X

X

X

X

 

 Week 16 telephone

                   

X

Clinical labs

 HIV testing

 

X

                  

 Pregnancy test (urine/serum)a

 

X

                  

 Full blood count

 

X

     

X

      

X

X

    

 CD4 count

 

X

                  

 ALT

 

X

     

X

      

X

X

    

 Urea, creatinine and electrolytes

 

X

 

X

 

X

 

X

  

X

 

X

 

X

X

    

 Drug levels

 

X

     

X

            

 Quantitative PCR sub-study

 

X

 

X

   

X

      

X

     

 Semi-quantitative cryptococcal antigen

 

X

                  

CSF

 Opening pressure

 

X

     

X

      

X

     

 Cell count and differentialb

 

X

                  

 Protein, glucoseb

 

X

                  

 Routine cultureb

 

X

                  

 India ink examinationb,c

 

X

                  

 Cryptococcal antigenb,c

 

X

                  

 Quantitative fungal culture

 

X

     

X

      

X

     

 CSF drug levels

 

X

     

X

      

X

     

 Immune parameters

 

X

     

X

      

X

     

 Semi-quantitative cryptococcal antigen

 

X

                  
  1. aFor women of childbearing age; bPart of routine care; cIndia ink or cryptococcal antigen required for inclusion